Patent ID: 11952585
Assignee: HOMOLOGY MEDICINES, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 11:
12. The method of claim 11, wherein the first immunosuppressant is administered according to the following sequential dosing regimen:
(1) 60 mg/day in prednisolone equivalents for two weeks;
(2) 40 mg/day in prednisolone equivalents for six weeks;
(3) 30 mg/day in prednisolone equivalents for three weeks;
(4) 20 mg/day in prednisolone equivalents for three weeks;
(5) 10 mg/day in prednisolone equivalents for five weeks; and
(6) 5 mg/day in prednisolone equivalents for one or two weeks.